tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
Advertisement

Keymed Biosciences, Inc. (2162) Revenue

Compare
1 Followers

Keymed Biosciences, Inc. Revenue

Keymed Biosciences, Inc. had a revenue of 498.75M in the quarter ending Jun 30, 2025, with 33.56%. This bring the company's revenue in the last twelve months to 872.19M, Decreased 103.72%. In the fiscal year ending Dec 31, 2024, Keymed Biosciences, Inc. had annual revenue of 428.12M with 20.91% growth.
Revenue (ttm)
872.19M
Revenue Growth
964.40%
P/S Ratio
49.51
Revenue/Employee
HK$340,321
Employees
1,258
Market Cap
HK$21.20B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
428.12M74.03M+120.91%
Dec 31, 2023
354.10M254.03M+353.87%
Dec 31, 2022
100.06M-10.21M+90.74%
Dec 31, 2021
110.27M-11,026,900,000.00%
Dec 31, 2020
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis